Target intelligence / Profile preview

Microbial cell wall and plasma membrane

Molecular classification
Structural component, Cellular barrier, Other
01

Overview

The microbial cell wall and plasma membrane are fundamental structures that maintain the physical integrity and physiological homeostasis of bacteria and fungi. The bacterial cell wall is characterized by a peptidoglycan layer that prevents osmotic rupture, while the underlying plasma membrane facilitates selective permeability and bioenergetic processes (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). In fungi, the cell wall is composed of chitin and glucans, and the plasma membrane contains ergosterol, which serves as a key structural component distinct from human cholesterol (Garcia-Rubio et al., 2020, J Fungi). These structures are among the most successful targets in antimicrobial therapy due to their essentiality for microbial survival and their distinct biochemical composition compared to host cells (Kapoor et al., 2017, J Family Med Prim Care). Therapeutic agents such as beta-lactams and glycopeptides disrupt cell wall assembly, whereas lipopeptides and polyenes target the membrane to induce lethal permeability (Lewis, 2013, Nat Rev Drug Discov). However, the clinical utility of targeting these structures is increasingly challenged by the emergence of complex resistance mechanisms and potential off-target toxicities in human tissues (Breijyeh et al., 2020, Molecules).

Other names
Bacterial cell wallFungal cell wallCytoplasmic membranePeptidoglycan layerMicrobial envelopeCell surface
02

Mechanism of action

Inhibition of peptidoglycan biosynthesis and cross-linking, disruption of cytoplasmic membrane integrity leading to ion leakage, inhibition of 1,3-beta-D-glucan synthesis in fungal cell walls, and binding to membrane sterols to form lethal pores.

03

Biological functions

Structural integrityOsmotic protectionSelective permeabilityCell divisionIon homeostasis
04

Disease associations

Bacterial infectionFungal infectionSepsisAntimicrobial resistance
05

Safety considerations

NephrotoxicityOtotoxicityHypersensitivity reactionsElectrolyte imbalancesDevelopment of multi-drug resistance (MDR)
06

Interacting drugs

Penicillin G

9 more in the full profile.

07

Biomarkers

Gram stainMinimum Inhibitory Concentration (MIC)1,3-beta-D-glucanGalactomannan

Beyond the preview

Go deeper on Microbial cell wall and plasma membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell wall and plasma membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call